Klein, Piers
Huo, Xiaochuan
Chen, Yimin
Abdalkader, Mohamad
Qiu, Zhongming
Nagel, Simon
Raymond, Jean
Liu, Liping
Siegler, James E.
Strbian, Daniel
Field, Thalia S.
Yaghi, Shadi
Qureshi, Muhammad M.
Demeestere, Jelle
Puetz, Volker
Berberich, Anne
Michel, Patrik
Fischer, Urs
Kaesmacher, Johannes
Yamagami, Hiroshi
Alemseged, Fana
Tsivgoulis, Georgios
Schonewille, Wouter J.
Hu, Wei
Liu, Xinfeng
Li, Chuanhui
Ji, Xunming
Drumm, Brian
Banerjee, Soma
Sacco, Simona
Sandset, Else C.
Kristoffersen, Espen Saxhaug
Slade, Peter
Mikulik, Robert
Romoli, Michele
Diana, Francesco
Krishnan, Kailash
Dhillon, Permesh
Lee, Jin Soo
Kasper, Ekkehard
Dasenbrock, Hormuzdiyar
Ton, Mai Duy
Masiliūnas, Rytis
Arsovska, Anita Ante
Marto, João Pedro
Dmytriw, Adam A.
Regenhardt, Robert W.
Silva, Gisele Sampaio
Siepmann, Timo
Sun, Dapeng
Sang, Hongfei
Diestro, Jose Danilo
Yang, Pengfei
Mohammaden, Mahmoud H.
Li, Fengli
Masoud, Hesham E.
Ma, Alice
Raynald,
Ganesh, Aravind
Liu, Jianmin
Meyer, Lukas
Dippel, Diederik W. J.
Thomalla, Götz
Parsons, Mark
Qureshi, Adnan I.
Goyal, Mayank
Yoo, Albert J.
Lapergue, Bertrand
Zaidat, Osama O.
Chen, Hui-Sheng
Campbell, Bruce C. V.
Jovin, Tudor G.
Nogueira, Raul G.
Miao, Zhongrong
Saposnik, Gustavo
Nguyen, Thanh N. http://orcid.org/0000-0002-2810-1685
Article History
Received: 4 January 2023
Accepted: 23 February 2023
First Online: 3 April 2023
Conflict of interest
: S. Nagel: consultancy for Brainomix, speaker with Boehringer Ingelheim, Pfizer. T.S. Field: research grants from Bayer, consultancy for HLS Therapeutics, Roche. V. Puetz: lecturer Daiichi Sankyo. U. Fischer: research grants from Medtronic, Stryker, Rapid Medical, Penumbra, Phenox, Swiss Science Foundation, Swiss Heart Foundation; consultant Medtronic, Stryker, CSL Behring; advisory board for Alexion/Portola, Boehringer Ingelheim. H. Yamagami: research grants Bristol Myers Squibb, lecturer Bayer, Daiichi-Sankyo, Stryker, Bristol-Myers Squib; advisory Daiichi-Sankyo. S. Sacco: research grants Novartis and Uriach; advisor/speaker Abbott, Allergan-Abbvie, AstraZeneca, Lilly, Lundbeck, Novartis, Novo Nordisk, Pfizer, Teva. R. Mikulik: project IRENE COST Action-Implementation Research Network in Stroke Care Quality, INTER-EXCELLENCE INTER-COST program of Ministry of Education, Youth and Sports of Czech Republic. J.E. Siegler: speaker with AstraZeneca. R. Masiliūnas: IRENE COST Action-Implementation Research Network in Stroke Care Quality. J.P. Marto: consulting Amicus Therapeutics, Boehringer Ingelheim; Speaker Boehringer Ingelheim. J.D. Diestro: Honoraria from Medtronic, travel grant from Microvention. G. Thomalla: consultant Acandis, Alexion, Amarin, Bayer, Bristol Myers Squibb/Pfizer, Boehringer Ingelheim, Portola, Stryker. M. Parsons: research Siemens, Canon, Apollo Medical Imaging. R.G. Nogueira: consulting Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, Synchron; advisory Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse, Perfuze; investments in Viz-AI, Perfuze, Cerebrotech, Reist/Q’Apel Medical, Truvic, Viseon. G. Saposnik: research grants, consulting from Roche; Editor-in-chief, World Stroke Academy. T.N. Nguyen: research support Medtronic, SVIN. P. Klein, X. Huo, Y. Chen, M. Abdalkader, Z. Qiu, J. Raymond, L. Liu, J.E. Siegler, D. Strbian, S. Yaghi, M.M. Qureshi, J. Demeestere, A. Berberich, P. Michel, J. Kaesmacher, F. Alemseged, G. Tsivgoulis, W.J. Schonewille, W. Hu, X. Liu, C. Li, X. Ji, B. Drumm, S. Banerjee, E.C. Sandset, E.S. Kristoffersen, P. Slade, M. Romoli, F. Diana, K. Krishnan, P. Dhillon, E. Kasper, H. Dasenbrock, M.D. Ton, A.A. Arsovska, A.A. Dmytriw, R.W. Regenhardt, G.S. Silva, T. Siepmann, D. Sun, H. Sang, P. Yang, M.H. Mohammaden, F. Li, H.E. Masoud, A. Ma, Raynald, A. Ganesh, J. Liu, L. Meyer, D.W.J. Dippel, A.I. Qureshi, M. Goyal, A.J. Yoo, B. Lapergue, O.O. Zaidat, H.-S. Chen, B.C.V. Campbell, T.G. Jovin, and Z. Miao declare that they have no competing interests.
Free to read: This content has been made available to all.